HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oncology
Sys. Review
Metabolic reprogramming and plasticity drive tumor progression and resistance through interconnected transcription factors and enzymes
Metabolic Plasticity Drives Cancer Growth and Resistance
This narrative review examines how metabolic reprogramming, driven by transcription factors like MYC and HIF-1α, facilitates cancer progress…
Cancer cells rewire their metabolism to fuel growth and resist treatment. A new review maps the complex network behind this process.
Frontiers
Jul 29, 2026
Oncology
Guideline
Hong Kong consensus statement updates management for locally advanced and metastatic renal cell carcinoma
New Kidney Cancer Rules Change How Doctors Treat Metastasis
This guideline presents a consensus statement developed by 6 urologists and 8 clinical oncologists in Hong Kong regarding locally advanced a…
New expert rules update kidney cancer care with more drug options and clearer surgery plans.
Frontiers
Apr 23, 2026